Status:
RECRUITING
Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure
Lead Sponsor:
Hong Kong University
Conditions:
Respiratory Failure
ICU
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care un...
Detailed Description
Extracorporeal carbon dioxide removal (ECCO2R) is a specialised medical procedure employed to eliminate excessive carbon dioxide (CO2) from the bloodstream. To date, there have been only a few small-s...
Eligibility Criteria
Inclusion
- Patients supported with ECCO2R in one of the designated study sites
- Admitted to the ICU between 1 Jan 2022 and 30 June 2024
Exclusion
- Patients younger than 18 years old
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT07161271
Start Date
November 1 2024
End Date
June 30 2027
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital (QMH)
Hong Kong, Hong Kong